References
- Barisani-AsenbauerTMacaSMMejdoubiLEmmingerWMacholdKAuerHUveitis–a rare disease often associated with systemic diseases and infections – a systematic review of 2619 patientsOrphanet J Rare Dis201275722932001
- JabsDANussenblattRBRosenbaumJTStandardization of Uveitis Nomenclature (SUN) Working GroupStandardization of uveitis nomenclature for reporting clinical data. Results of the First International WorkshopAm J Ophthalmol2005140350951616196117
- GangaputraSNewcombCWLiesegangTLSystemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Methotrexate for ocular inflammatory diseasesOphthalmology2009116112188219819748676
- LevyRAde AndradeFAFoeldvariICutting-edge issues in autoimmune uveitisClin Rev Allergy Immunol201141221422321913066
- MetzingerJLFosterCS‘Approved for use in uveitis’: drug approval for an orphan diseaseExpert Opin Orphan Drugs201537799807
- Developing Products for Rare Diseases & ConditionsDesignation an Orphan Product: Drug and Biological Products: Searchable Databases for Orphan Designated and or Approved Products. U.S. Food and Drug Administration2016 Available from: http://www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfmAccessed January 27, 2016
- GilmanAGRallTWNiesASTaylorPGoodman and Gilman’s the Pharmacological Basis of TherapeuticsNew York, NYPergamon Press1990
- WeinblattMECoblynJSFoxDAEfficacy of low dose methotrexate in rheumatoid arthritisN Engl J Med1985312138188223883172
- ShahSSLowderCYSchmittMAWilkeWSKosmorskyGSMeislerDMLow-dose methotrexate therapy for ocular inflammatory diseaseOphthalmology1992999141914231407973
- RossiSAustralian Medicines Handbook AdelaideAustraliaThe Australian Medicines Handbook Unit Trust2013
- Joint Formulary CommitteeBritish National Formulary (BNF)65th edLondon, UKPharmaceutical Press2013
- LimaBRNussenblattRBSenHNPharmacogenetics of drugs used in the treatment of ocular inflammatory diseasesExpert Opin Drug Metab Toxicol20139787588223521173
- GalorAJabsDALederHAComparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammationOphthalmology2008115101826183218579209
- ImrieFRDickADNonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitisCurr Opin Ophthalmol200718321221917435428
- BaughmanRPLowerEEIngledueRKaufmanAHManagement of ocular sarcoidosisSarcoidosis Vasc Diffuse Lung Dis2012291263323311120
- LarsonTNussenblattRBSenHNEmerging drugs for uveitisExpert Opin Emerg Drugs201116230932221210752
- BachJHThe Mode of Action of Immunosuppressive DrugsAmsterdam, the NetherlandsElsevier1975
- TaylorSRHabot-WilnerZPachecoPLightmanSLIntraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edemaOphthalmology2009116479780119344827
- KinoTHatanakaHHashimotoMFK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physicochemical and biological characteristicsJ Antibiot (Tokyo)1987409124912552445721
- IshiokaMOhnoSNakamuraSFK506 treatment of noninfectious uveitisAm J Ophthalmol199411867237297526689
- HoganACMcAvoyCEDickADLeeRWLong-term efficacy and tolerance of tacrolimus for the treatment of uveitisOphthalmology200711451000100617467532
- LeeRWGreenwoodRTaylorHA randomized trial of tacrolimus versus tacrolimus and prednisone for the maintenance of disease remission in noninfectious uveitisOphthalmology201211961223123022381809
- MurphyCCGreinerKPlskovaJCyclosporine vs tacrolimus therapy for posterior and intermediate uveitisArch Ophthalmol2005123563464115883282
- LeeYJKimSWSeoKYApplication for tacrolimus ointment in treating refractory inflammatory ocular surface diseasesAm J Ophthalmol2013155580481323394907
- LindstedtEWBaarsmaGSKuijpersRWvan HagenPMAnti-TNF-alpha therapy for sight threatening uveitisBr J Ophthalmol200589553353615834077
- SuhlerEBSmithJRGilesTRInfliximab therapy for refractory uveitis: 2-year results of a prospective trialArch Ophthalmol2009127681982219506209
- AridaAFragiadakiKGiavriESfikakisPPAnti-TNF agents for Behcet’s disease: analysis of published data on 369 patientsSemin Arthritis Rheum2011411617021168186
- SuhlerEBSmithJRWertheimMSA prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomesArch Ophthalmol2005123790391216009830
- SfikakisPPKaklamanisPHElezoglouAInfliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behcet diseaseAnn Intern Med2004140540440614996689
- TabbaraKFAl-HemidanAIInfliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet diseaseAm J Ophthalmol20081466845.e1850.e118929351
- RichardsJCTay-KearneyMLMurrayKMannersPInfliximab for juvenile idiopathic arthritis-associated uveitisClin Experiment Ophthalmol200533546146816181269
- TynjalaPLindahlPHonkanenVLahdennePKotaniemiKInfliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritisAnn Rheum Dis200766454855017068061
- ClementineRRLymanJZakemJMallepalliJLindseySQuinetRTumor necrosis factor-alpha antagonist-induced sarcoidosisJ Clin Rheumatol201016627427920808167
- OlivierAGilsonBLafontaineSPautotJXBindiPPulmonary and renal involvement in a TNFα antagonist drug-induced sarcoidosisRev Med Interne2012335e25e2721592629
- Cordero-ComaMBenitoMFHernandezAMAntolinSCRuizJMSerpiginous choroiditisOphthalmology2008115916331633.e1e2.3618762076
- DoychevaDDeuterCStuebigerNZierhutMInterferon-alpha-associated presumed ocular sarcoidosisGraefes Arch Clin Exp Ophthalmol2009247567568019034483
- AlazemiSCamposMAInterferon-induced sarcoidosisInt J Clin Pract200660220121116451294
- PlskovaJGreinerKForresterJVInterferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitisAm J Ophthalmol20071441556117601428
- PlskovaJGreinerKMuckersieEDuncanLForresterJVInterferon-alpha: a key factor in autoimmune disease?Invest Ophthalmol Vis Sci20064793946395016936109
- Tugal-TutkunIGuney-TefekliEUrganciogluMResults of interferon-alfa therapy in patients with Behcet uveitisGraefes Arch Clin Exp Ophthalmol2006244121692169516673135
- BodaghiBGendronGWechslerBEfficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patientsBr J Ophthalmol200791333533917050581
- BulterNJSuhlerEBRosenbaumJTInterferon alpha 2b in the treatment of cystoid macular edemaOcul Immunol Inflamm2012202869022409560
- BeckerMDHeiligenhausAHuddeTInterferon as a treatment for uveitis associated with multiple sclerosisBr J Ophthalmol200589101254125716170111
- CirinoACMathuraJRJrJampolLMResolution of activity (choroiditis and choroidal neovascularization) of chronic recurrent punctate inner choroidopathy after treatment with interferon B-1ARetina20062691091109217151504
- MiserocchiEModoratiGBerchicciLPontikakiIMeroniPGerloniVLong-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitisBr J Ophthalmol2016100678278626396026
- MiserocchiEPontikakiIModoratiGBandelloFMeroniPLGerloniVRituximab for uveitisOphthalmology2011118122322421199719
- HeiligenhausAMiserocchiEHeinzCGerloniVKotaniemiKTreatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)Rheumatology (Oxford)20115081390139421378109
- HickmanRADennistonAKYeeCSToescuVMurrayPIGordonCBilateral retinal vasculitis in a patient with systemic lupus erythematodes and its remission with rituximab therapyLupus201019332732919900982
- DavatchiFShamsHRezaipoorMRituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)Int J Rheum Dis201013324625220704622
- Tomkins-NetzerOTaylorSRLightmanSCan rituximab induce long-term disease remission in patients with intra-ocular non-infectious inflammation?Ophthalmologica2013230310911523948944
- NicholsonLSobrinLAnterior uveitis secondary to type II essential cryoglobulinemiaJ Ophthalmic Inflamm Infect2013315623883484
- TappeinerCHeinzCGanserGHeiligenhausAIs tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?J Rheumatol201239612941295
- TsangACRothJGottliebCTocilizumab for severe chronic anterior uveitis associated with juvenile idiopathic arthritis in a pediatric patientOcul Immunol Inflamm201422215515724377416
- MesquidaMLeszczynskaALlorencVAdánAInterleukin-6 blockade in ocular inflammatory diseasesClin Exp Immunol2014176330130924528300
- AdánAMesquidaMLlorencVTocilizumab treatment for refractory uveitis-related cystoid macular edemaGraefes Arch Clin Exp Ophthalmol2013251112627263223893042
- MesquidaMMolinsBLlorencVSainz de la MazaMAdánALong-term effects of tocilizumab therapy for refractory uveitis-related macular edemaOphthalmology2014121122380238625204610
- PapoMBielefeldPValletHTocilizumab in severe and refractory non-infectious uveitisClin Exp Rheumatol2014324 Suppl 84875879
- HiranoTOhguroNHohkiSA case of Behcet’s disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumabMod Rheumatol201222229830221748365
- OshitariTKajitaFTobeARefractory uveitis in patient with castleman disease successfully treated with tocilizumabCase Rep Ophthalmol Med2012201296818023198204
- LinPTargeting interleukin-6 for noninfectious uveitisClin Ophthalmol201591697170226392750
- WendlingDDernisEPratiCFrischEDelboscBOnset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?J Rheumatol20113810228421965707
- CantariniLVitaleAScaliniPAnakinra treatment in drug-resistant Behcet’s disease: a case seriesClin Rheumatol20153471293130124305945
- TeohSCSharmaSHoganALeeRRamananAVDickADTailoring biological treatment: anakinra treatment of posterior uveitis associated with the CINCA syndromeBr J Ophthalmol200791226326417244662
- AlexanderTKlotzOFeistERütherKBurmesterGRPleyerUSuccessful treatment of acute visual loss in Muckle-Wells syndrome with interleukin 1 receptor antagonistAnn Rheum Dis20056481245124616014694
- ArósteguiJIArnaCMerinoRNOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin 1 blockade in a Spanish cohortArthritis Rheum200756113805381317968944
- VitaleARiganteDCasoFInhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet’s disease: a case seriesDermatology2014228321121424642905
- UgurluSUcarDSeyahiEHatemiGYurdakulSCanakinumab in a patient with juvenile Behcet’s syndrome with refractory eye diseaseAnn Rheum Dis20127191589159122586166
- SimoniniGXuZCaputoRClinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitisArthritis Rheum201365251351823124805
- BuggageRRLevy-ClarkeGSenHNA double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behcet’s diseaseOcul Immunol Inflamm2007152637017558830
- IsaacsJDHaleGWaldmannHMonoclonal antibody therapy of chronic intraocular inflammation using Campath-1HBr J Ophthalmol19957911105410558534657
- DickADMeyerPJamesTCampath-1H therapy in refractory ocular inflammatory diseaseBr J Ophthalmol200084110710910611109
- LockwoodCMHaleGWaldmannHJayneDRRemission induction in Behcet’s disease following lymphocyte depletion by the anti-CD52 antibody CAMPATH-1HRheumatology (Oxford)200342121539154412949252